- What is Medvest's primary investment focus?
- Medvest is a UK-based company that invests in Israeli medtech and digital health products, focusing on safety and efficiency through big data analytics and enhanced patented technologies.
- Can you name some of Medvest's portfolio companies?
- Medvest's portfolio includes CardioSert, which develops advanced tools for interventional cardiologists, and Rapidx, which focuses on at-home rapid diagnostic tests.
- What is Medvest's investment stage preference?
- Medvest invests across various stages, including Pre-Seed, Seed, A Round, and B Round.
- Has Medvest had any notable exits?
- Yes, Medvest had an exit in May 2018 when its portfolio company CardioSert was acquired by Microbot Medical for $370K.
- What is Medvest's geographic focus for investments?
- Medvest specifically invests in Israeli medtech and digital health products, with a focus on bringing these products to as many markets as possible through local partnerships.
- What is Medvest's approach to portfolio company development?
- Medvest aims to accelerate products to commercialization through a common ecosystem, achieve significant or controlling shareholdings for larger returns on exits, and expand offerings through product development and acquisitions.
- Who are the key individuals on Medvest's team?
- The key individuals on Medvest's team include Avi Azulai, Founder & Managing Partner, and Joaquin Gari and David Akunis, both Managing Partners.